These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35798365)

  • 1. Exit means exit for Boris Johnson?
    Cowper A
    BMJ; 2022 Jul; 378():o1690. PubMed ID: 35798365
    [No Abstract]   [Full Text] [Related]  

  • 2. Boris Johnson and health: unfulfilled promises.
    McKee M
    BMJ; 2022 Jul; 378():o1707. PubMed ID: 35817466
    [No Abstract]   [Full Text] [Related]  

  • 3. Brexit backer Boris Johnson stokes fears for U.K. scientists.
    Stokstad E
    Science; 2019 Aug; 365(6452):418. PubMed ID: 31371588
    [No Abstract]   [Full Text] [Related]  

  • 4. Boris Johnson is criticised for repeating claims that NHS will benefit from Brexit.
    Iacobucci G
    BMJ; 2018 Jan; 360():k240. PubMed ID: 29343492
    [No Abstract]   [Full Text] [Related]  

  • 5. Offline: Boris Johnson and COVID-19-more light than heat.
    Horton R
    Lancet; 2023 Dec; 402(10419):2277. PubMed ID: 38103935
    [No Abstract]   [Full Text] [Related]  

  • 6. Public health leaders slam Boris Johnson over "sin tax" review plan.
    Iacobucci G
    BMJ; 2019 Jul; 366():l4557. PubMed ID: 31272997
    [No Abstract]   [Full Text] [Related]  

  • 7. Donald Trump, Boris Johnson, and other leaders win Ig Nobel awards for teaching people about life and death.
    Tanne JH
    BMJ; 2020 Sep; 370():m3675. PubMed ID: 32948527
    [No Abstract]   [Full Text] [Related]  

  • 8. Maintaining an optimum haemocatheter exit site.
    Wittich E
    EDTNA ERCA J; 2001; 27(2):81-2. PubMed ID: 11868754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the brother of the regulator of imprinted sites gene in the sputum of patients with lung cancer.
    Lee HY; Kim JI; Cho SH; Ko TY; Kim HS; Park SD; Cho SR; Chang HK; Hwang GJ; Jung SB
    Korean J Thorac Cardiovasc Surg; 2014 Aug; 47(4):378-83. PubMed ID: 25207247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atractyloside mimics
    Fang M; Song Y; Ren J; Yuan H; Fang J; Yan D; Zhang Y; Wang X
    Int J Clin Exp Pathol; 2018; 11(7):3286-3293. PubMed ID: 31949703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of transcription factor BORIS and its association with the estrogen receptor beta (ER-β) in cervical carcinogenesis.
    López-Romero R; Rodríguez-Esquivel M; Romero-Morelos P; García-Avilés JE; Serafín-Castillo A; Huerta-Padilla VM; Guerra-Araiza C; Mantilla-Morales A; Monrroy-García A; Aguilar-Urbano MA; Martínez-Castillo MA; Jiménez-Tenorio JA; Salcedo M
    Int J Clin Exp Pathol; 2019; 12(9):3208-3221. PubMed ID: 31934165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The downregulation of putative anticancer target BORIS/CTCFL in an addicted myeloid cancer cell line modulates the expression of multiple protein coding and ncRNA genes.
    Teplyakov E; Wu Q; Liu J; Pugacheva EM; Loukinov D; Boukaba A; Lobanenkov V; Strunnikov A
    Oncotarget; 2017 Sep; 8(43):73448-73468. PubMed ID: 29088719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective apoptosis of breast cancer cells by siRNA targeting of BORIS.
    Dougherty CJ; Ichim TE; Liu L; Reznik G; Min WP; Ghochikyan A; Agadjanyan MG; Reznik BN
    Biochem Biophys Res Commun; 2008 May; 370(1):109-12. PubMed ID: 18355444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.
    D'Arcy V; Pore N; Docquier F; Abdullaev ZK; Chernukhin I; Kita GX; Rai S; Smart M; Farrar D; Pack S; Lobanenkov V; Klenova E
    Br J Cancer; 2008 Feb; 98(3):571-9. PubMed ID: 18195709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicians, scientists, and public health experts call for Boris Johnson to listen to climate activist on hunger strike.
    BMJ; 2022 Apr; 377():o987. PubMed ID: 35430562
    [No Abstract]   [Full Text] [Related]  

  • 16. BORIS in human cancers -- a review.
    Martin-Kleiner I
    Eur J Cancer; 2012 Apr; 48(6):929-35. PubMed ID: 22019212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma.
    He J; Huang Y; Liu Z; Zhao R; Liu Q; Wei L; Yu X; Li B; Qin Y
    Gene; 2017 Sep; 629():29-34. PubMed ID: 28764977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BORIS/CTCFL is an RNA-binding protein that associates with polysomes.
    Ogunkolade BW; Jones TA; Aarum J; Szary J; Owen N; Ottaviani D; Mumin MA; Patel S; Pieri CA; Silver AR; Sheer D
    BMC Cell Biol; 2013 Nov; 14():52. PubMed ID: 24279897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of the monoclonal antibodies against human BORIS and the expression pattern of BORIS in normal and diseased human mammary tissues].
    Zhou XC; Song CJ; Wang X; Tian Y; Jin BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):353-5. PubMed ID: 17428394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of BORIS/CTCFL leads to ROS-dependent cellular senescence and drug sensitivity in MYCN-amplified neuroblastoma.
    Rao GK; Makani VKK; Mendonza JJ; Edathara PM; Patel N; Ramakrishna M; Cilamkoti P; Chiring Phukon J; Jose J; Bhadra U; Bhadra MP
    FEBS J; 2022 May; 289(10):2915-2934. PubMed ID: 34854238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.